{Reference Type}: Case Reports
{Title}: A Case Series on Post-COVID Tuberculosis: An Underrated Duo of COVID-19 and Tuberculosis.
{Author}: Rajagopal J;Konaka Gautamdas S;Sivakumar G;Ramaraju K;
{Journal}: Cureus
{Volume}: 15
{Issue}: 10
{Year}: 2023 Oct
暂无{DOI}: 10.7759/cureus.48013
{Abstract}: In India, tuberculosis (TB) has the second highest disease burden following diabetes mellitus. During the COVID-19 pandemic, there was a surge of several opportunistic infections. In this case series, we report five patients, including three adults and two adolescents, who have developed various forms of TB disease after symptomatic COVID-19 pneumonia. The average time for development of post-COVID TB was 48 days. Adolescent patients have developed disseminated TB, which can be due to COVID-19-induced immunological injury or its treatment-related immune suppression. All the adult patients had high CT severity scores (CTSS) and required the administration of intravenous steroids during their COVID-19 pneumonia. Various presentations of TB were secondary spontaneous pneumothorax, miliary TB, consolidation, and nodular infiltrates. One patient had a drug-induced liver injury, which complicated the treatment of that patient. Factors that may contribute to the development of post-COVID TB are diabetes mellitus, increased severity of COVID-19 pneumonia manifested by CTSS, and administration of intravenous steroids. Bidirectional screening of TB had to be done when patients present with symptoms of COVID-19 pneumonia.